Havas Health & You announces strategic partnership with Trinity Life Sciences
Summary
As part of the deal, the 2022 MM+M Agency 100 honoree is taking a minority stake in Trinity.The move is the first major news unveiled by HH&Y in 2023 following a busy 2022.In December, the company announced a global partnership with Evermed, an HCP engagement company, to expand its content solutions for doctors and other clinical workers. Earlier in the year, HH&Y teamed with Republica Havas to launch Republica Havas Health.HH&Y also made a series of leadership changes throughout the year, including naming Paul Kinsella as chief creative officer of HH&Y Europe, Paul Pfleiderer as president of Havas Life New York, Laura Mizrahi as CCO at its flagship H4B Chelsea agency and Elizabeth Egan as CEO of HH&Y Europe.The rapid and dynamic pace of the life sciences industry requires we take a more comprehensive view to move smarter and faster. The company also partnered with Bain & Co. last year as well.When we started to talk about the potential partnership, it became clear that both Trinity and Havas Health & You had missions that were solidly aligned. To layer on sophisticated data, insights and analytics to branding and communications programs for our collective life science clients will be industry-changing. Addressing key areas such as launch, customer experience and application of technologies to advance omnichannel will be our focus.